# US 2023/0054761 A1 · Expanded foam for delivery of functional ingredients

> Agents: this data is available as JSON from the patentgrep API and MCP server — see https://patentgrep.com/llms.txt

- Number: US 2023/0054761 A1
- Document ID: US20230054761A1
- Status: Published application
- Kind: A1
- Application number: 17/759,132
- Filed: 2021-01-19
- Published: 2023-02-23
- Earliest claimed: 2020-01-21
- Assignees: Boehringer Ingelheim Vetmedica GmbH; Westgate Biomedical Ltd.
- Applicants: Boehringer Ingelheim Vetmedica GmbH; Westgate Biomedical Limited
- Inventors: Michael A. FOLAN; David J. FOLAN
- Web page: https://patentgrep.com/patent/US20230054761A1

## CPC

- A23K 20/26: Compounds containing phosphorus
- A61K 9/0056: {Mouth soluble or dispersible forms; Suckable, eatable, chewable coherent forms; Forms rapidly disintegrating in the mouth; Lozenges; Lollipops; Bite capsules; Baked products; Baits or other oral forms for animals}
- A23K 50/42: Dry feed
- A23L 15/20: {Addition of proteins, e.g. hydrolysates, fats, carbohydrates, natural plant hydrocolloids; Addition of animal or vegetable substances containing proteins, fats, or carbohydrates}
- A23L 29/231: Pectin; Derivatives thereof
- A23L 29/256: from seaweeds, e.g. alginates, agar or carrageenan
- A23L 29/281: Proteins, e.g. gelatin or collagen
- A23L 29/284: {Gelatin; Collagen}
- A23L 33/10: using additives (addition of substantially indigestible substances A23L33/21)
- A61K 47/02: Inorganic compounds
- A61K 47/12: Carboxylic acids; Salts or anhydrides thereof
- A61K 47/36: Polysaccharides; Derivatives thereof, e.g. gums, starch, alginate, dextrin, hyaluronic acid, chitosan, inulin, agar or pectin
- A61K 47/42: Proteins; Polypeptides; Degradation products thereof; Derivatives thereof, e.g. albumin, gelatin or zein (oligopeptides having up to five amino acids {A61K47/183}; polyamino acids A61K47/34)
- A23K: FODDER
- A61K: PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES (devices or methods specially adapted for bringing pharmaceutical products into particular physical or administering forms A61J3/00; chemical aspects of, or use of materials for deodorisation of air, for disinfection or sterilisation, or for bandages, dressings, absorbent pads or surgical articles A61L; soap compositions C11D)
- A23L: FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES, NOT OTHERWISE PROVIDED FOR; PREPARATION OR TREATMENT THEREOF (preservation thereof A23B)

## Abstract

The present disclosure provides delivery systems for functional ingredients, such as drugs, nutritional supplements, botanicals, and vitamins. The delivery systems comprise an ingestible matrix within which the functional ingredient(s) are substantially uniformly and completely dispersed. The matrix comprises foams derived by physical shear of egg white to achieve amplified available dose and improved release characteristics of functional ingredients at skin and mucosal surfaces for healthcare purposes. The disclosure also provides methods of preparing and using the delivery systems.

## Claims

### Claim 1

A delivery system for functional ingredients comprising one or more functional ingredient(s) substantially uniformly dispersed in a matrix, wherein said matrix comprises:
i) an egg white component comprising between 1-50% protein;
ii) one or more heat resistant and/or heat sensitive gelling agents;
iii) a pH regulator;
iv) one or more plasticizers and/or humectants; and
v) one or more source of water.

### Claim 2 (depends on 1)

The delivery system according to claim 1, wherein said one or more gelling agents comprises agar.

### Claim 3 (depends on 1)

The delivery system according to claim 1, wherein said one or more gelling agents comprises gelatin.

### Claim 4 (depends on 1)

The delivery system according to claim 1, wherein said one or more gelling agents comprises pectin.

### Claim 5 (depends on 1)

The delivery system according to claim 1, wherein said one or more gelling agents comprises at least two gelling agents selected from agar, gelatin, and pectin.

### Claim 6 (depends on 1)

The delivery system according to claim 1, wherein said pH regulator is citric acid.

### Claim 7 (depends on 1)

The delivery system according to claim 1, wherein said one or more functional ingredient(s) comprises a functional emulsion.

### Claim 8 (depends on 1)

The delivery system according to claim 1, comprising two or more functional ingredient(s).

### Claim 9 (depends on 7)

The delivery system according to claim 7, further comprising a chelating agent.

### Claim 10 (depends on 9)

The delivery system according to claim 9, wherein the chelating agent is a polyphosphate.

### Claim 11 (depends on 10)

The delivery system according to claim 10, wherein the polyphosphate is sodium hexametaphosphate.

### Claim 12 (depends on 1)

The delivery system according to claim 1, wherein said one or more functional ingredients are selected from the group of drugs, botanicals, nutritional supplements, vitamins, minerals, enzymes, hormones, proteins, polypeptides and antigens.

### Claim 13 (depends on 1)

The delivery system according to claim 1, further comprising a sweetener, a buffer, a natural or artificial flavoring, a coloring agent, or a combination thereof.

### Claim 14 (depends on 1)

A dual action dental chew for dogs, wherein the dental chew comprises two components; a flexible base and a filling, and wherein the filling comprises the delivery system according to claim 1.

### Claim 15 (depends on 14)

The dual action dental chew for dogs according to claim 14, wherein the flexible base is shaped and designed to reduce plaque and calculus through mechanical action (scrubbing, abrasion) during the chewing process, and wherein the chew base features a ‘reservoir’/cavity for the filling.

### Claim 16 (depends on 14)

The dual action dental chew for dogs according to claim 14, wherein the delivery system comprises a functional ingredient comprising an emulsion comprising (a) one or more saturated or unsaturated free fatty acids having from 4 to 22 carbon atoms or a pharmaceutically acceptable salt thereof; and (b) one or more delipidised membrane lipids, as emulsifying agent for the free fatty acid(s) or the salt thereof.

### Claim 17 (depends on 1)

A method of using the delivery system according to claim 1 for oral administration of one or more functional ingredient to an animal in need thereof comprising administering the delivery system to the animal in need.
